180 related articles for article (PubMed ID: 26857577)
1. Limitations of Murine Models for Assessment of Antibody-Mediated Therapies or Vaccine Candidates against Staphylococcus epidermidis Bloodstream Infection.
Cole LE; Zhang J; Kesselly A; Anosova NG; Lam H; Kleanthous H; Yethon JA
Infect Immun; 2016 Apr; 84(4):1143-1149. PubMed ID: 26857577
[TBL] [Abstract][Full Text] [Related]
2. A Single B-repeat of Staphylococcus epidermidis accumulation-associated protein induces protective immune responses in an experimental biomaterial-associated infection mouse model.
Yan L; Zhang L; Ma H; Chiu D; Bryers JD
Clin Vaccine Immunol; 2014 Sep; 21(9):1206-14. PubMed ID: 24920603
[TBL] [Abstract][Full Text] [Related]
3. TLR2 mediates recognition of live Staphylococcus epidermidis and clearance of bacteremia.
Strunk T; Power Coombs MR; Currie AJ; Richmond P; Golenbock DT; Stoler-Barak L; Gallington LC; Otto M; Burgner D; Levy O
PLoS One; 2010 Apr; 5(4):e10111. PubMed ID: 20404927
[TBL] [Abstract][Full Text] [Related]
4. Staphylococcus aureus manganese transport protein C is a highly conserved cell surface protein that elicits protective immunity against S. aureus and Staphylococcus epidermidis.
Anderson AS; Scully IL; Timofeyeva Y; Murphy E; McNeil LK; Mininni T; Nuñez L; Carriere M; Singer C; Dilts DA; Jansen KU
J Infect Dis; 2012 Jun; 205(11):1688-96. PubMed ID: 22474033
[TBL] [Abstract][Full Text] [Related]
5. A neonatal model of intravenous Staphylococcus epidermidis infection in mice <24 h old enables characterization of early innate immune responses.
Kronforst KD; Mancuso CJ; Pettengill M; Ninkovic J; Power Coombs MR; Stevens C; Otto M; Mallard C; Wang X; Goldmann D; Levy O
PLoS One; 2012; 7(9):e43897. PubMed ID: 22970147
[TBL] [Abstract][Full Text] [Related]
6. Staphylococcus epidermidis Bacteremia Induces Brain Injury in Neonatal Mice via Toll-like Receptor 2-Dependent and -Independent Pathways.
Bi D; Qiao L; Bergelson I; Ek CJ; Duan L; Zhang X; Albertsson AM; Pettengill M; Kronforst K; Ninkovic J; Goldmann D; Janzon A; Hagberg H; Wang X; Mallard C; Levy O
J Infect Dis; 2015 Nov; 212(9):1480-90. PubMed ID: 25883383
[TBL] [Abstract][Full Text] [Related]
7. Protection against Staphylococcus aureus Colonization and Infection by B- and T-Cell-Mediated Mechanisms.
Zhang F; Ledue O; Jun M; Goulart C; Malley R; Lu YJ
mBio; 2018 Oct; 9(5):. PubMed ID: 30327437
[No Abstract] [Full Text] [Related]
8. Vaccine protection of leukopenic mice against Staphylococcus aureus bloodstream infection.
Rauch S; Gough P; Kim HK; Schneewind O; Missiakas D
Infect Immun; 2014 Nov; 82(11):4889-98. PubMed ID: 25183728
[TBL] [Abstract][Full Text] [Related]
9. Involvement of the Iron-Regulated Loci
Oliveira F; Lima T; Correia A; Silva AM; Soares C; Morais S; Weißelberg S; Vilanova M; Rohde H; Cerca N
Microbiol Spectr; 2022 Feb; 10(1):e0216821. PubMed ID: 35019768
[TBL] [Abstract][Full Text] [Related]
10. Host Response to
Nguyen TH; Park MD; Otto M
Front Cell Infect Microbiol; 2017; 7():90. PubMed ID: 28377905
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of conjugated PIA-rSesC and immunological evaluation against biofilm-forming Staphylococcus epidermidis.
Mirzaei B; Mousavi SF; Babaei R; Bahonar S; Siadat SD; Shafiee Ardestani M; Shahrooei M; Van Eldere J
J Med Microbiol; 2019 May; 68(5):791-802. PubMed ID: 30990402
[TBL] [Abstract][Full Text] [Related]
12. Immunoprophylaxis and immunotherapy of Staphylococcus epidermidis infections: challenges and prospects.
Van Mellaert L; Shahrooei M; Hofmans D; Eldere JV
Expert Rev Vaccines; 2012 Mar; 11(3):319-34. PubMed ID: 22380824
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of serotypes 5 and 8 capsular polysaccharides in protection against Staphylococcus aureus in murine models of infection.
Cheng BL; Nielsen TB; Pantapalangkoor P; Zhao F; Lee JC; Montgomery CP; Luna B; Spellberg B; Daum RS
Hum Vaccin Immunother; 2017 Jul; 13(7):1609-1614. PubMed ID: 28422567
[TBL] [Abstract][Full Text] [Related]
14. Development of a rat central venous catheter model for evaluation of vaccines to prevent Staphylococcus epidermidis and Staphylococcus aureus early biofilms.
Ebert T; Smith S; Pancari G; Wu X; Zorman J; Clark D; Cook J; Burns C; Antonello JM; Cope L; Nagy E; Meinke A; McNeely T
Hum Vaccin; 2011 Jun; 7(6):630-8. PubMed ID: 21508677
[TBL] [Abstract][Full Text] [Related]
15. Soluble TLR2 reduces inflammation without compromising bacterial clearance by disrupting TLR2 triggering.
Raby AC; Le Bouder E; Colmont C; Davies J; Richards P; Coles B; George CH; Jones SA; Brennan P; Topley N; Labéta MO
J Immunol; 2009 Jul; 183(1):506-17. PubMed ID: 19542461
[TBL] [Abstract][Full Text] [Related]
16. Preclinical Efficacy of Clumping Factor A in Prevention of Staphylococcus aureus Infection.
Li X; Wang X; Thompson CD; Park S; Park WB; Lee JC
mBio; 2016 Feb; 7(1):e02232-15. PubMed ID: 26838725
[TBL] [Abstract][Full Text] [Related]
17. Staphylococcus epidermidis as a cause of bacteremia.
Kleinschmidt S; Huygens F; Faoagali J; Rathnayake IU; Hafner LM
Future Microbiol; 2015; 10(11):1859-79. PubMed ID: 26517189
[TBL] [Abstract][Full Text] [Related]
18. A D-Alanine auxotrophic live vaccine is effective against lethal infection caused by Staphylococcus aureus.
Moscoso M; García P; Cabral MP; Rumbo C; Bou G
Virulence; 2018 Jan; 9(1):604-620. PubMed ID: 29297750
[TBL] [Abstract][Full Text] [Related]
19. Vaccination with SesC decreases Staphylococcus epidermidis biofilm formation.
Shahrooei M; Hira V; Khodaparast L; Khodaparast L; Stijlemans B; Kucharíková S; Burghout P; Hermans PW; Van Eldere J
Infect Immun; 2012 Oct; 80(10):3660-8. PubMed ID: 22802343
[TBL] [Abstract][Full Text] [Related]
20. Vaccines targeting Staphylococcus aureus skin and bloodstream infections require different composition.
Luna BM; Nielsen TB; Cheng B; Pantapalangkoor P; Yan J; Boyle-Vavra S; Bruhn KW; Montgomery C; Spellberg B; Daum R
PLoS One; 2019; 14(6):e0217439. PubMed ID: 31181086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
